(c) 2024 PillSync.com

glipizide 5 mg

INDICATIONS AND USAGE Glipizide Tablets USP are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

ani pharmaceuticals, inc.


2 years ago ROUND WHITE ANI 315 glipizide 5 mg

ROUND WHITE ANI 315

2 years ago ROUND WHITE ANI 315 glipizide 5 mg

ANI 315 ROUND WHITE

HOW SUPPLIED

GLIPIZIDE Tablets USP, 5 mg are available as white to off-white, round, flat-faced, beveled edge tablets, bisected and debossed on one side with “315” above bisect and debossed with “ANI” on the other side, containing 5 mg of

GLIPIZIDE. They are available in: Bottles of 100 tablets NDC 62559-315-01 Bottles of 1000 tablets NDC 62559-315-10

GLIPIZIDE Tablets USP, 10 mg are available as white to off-white, round, flat-faced, beveled edge tablets, bisected and debossed on one side with “316” above bisect and debossed with “ANI” on the other side, containing 10 mg of

GLIPIZIDE. They are available in: Bottles of 100 tablets NDC 62559-316-01 Bottles of 1000 tablets NDC 62559-316-10 Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required). KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. All brand names listed are the registered trademarks of their respective owners and are not trademarks of ANI Pharmaceuticals, Inc. Distributed by: ANI Pharmaceuticals, Inc. Baudette, MN 56623 Issued: 08/2022 LB4530-00 logo


More pills like ROUND ANI 315












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site